Page last updated: 2024-09-04

beta-lactams and cefiderocol

beta-lactams has been researched along with cefiderocol in 8 studies

Compound Research Comparison

Studies
(beta-lactams)
Trials
(beta-lactams)
Recent Studies (post-2010)
(beta-lactams)
Studies
(cefiderocol)
Trials
(cefiderocol)
Recent Studies (post-2010) (cefiderocol)
7,5791793,39525014249

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (25.00)24.3611
2020's6 (75.00)2.80

Authors

AuthorsStudies
Auguste, PS; Bumann, D; Köhler, T; Luscher, A; Mazza, L; Moynié, L; Naismith, JH; Pletzer, D1
Page, MGP1
Bassetti, M; Battaglini, D; Giacobbe, DR; Pelosi, P; Vena, A1
Ibrahim, D; Jabbour, JF; Kanj, SS1
Abbaszadeh, F; Baradaran, B; Dehghani, L; Hasani, A; Rezaee, MA; Samadi Kafil, H; Vahhabi, A1
Kusaksizoglu, A; Nordmann, P; Ortiz de la Rosa, JM; Poirel, L; Sadek, M; Sakaoglu, Z1
Azanza Perea, JR; Sádaba Díaz de Rada, B1
Bakathavatchalam, YD; C, GPD; D, TK; Gopikrishnan, M; Manesh, A; Ramireddy, S; Varghese, RP; Veeraraghavan, B; Walia, K1

Reviews

4 review(s) available for beta-lactams and cefiderocol

ArticleYear
The role of new antimicrobials for Gram-negative infections in daily clinical practice.
    Current opinion in infectious diseases, 2020, Volume: 33, Issue:6

    Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azabicyclo Compounds; beta-Lactams; Carbapenems; Cefiderocol; Ceftazidime; Cephalosporins; Drug Combinations; Drug Resistance, Bacterial; Gram-Negative Bacterial Infections; Humans; Imipenem; Microbial Sensitivity Tests; Polymyxins; Sisomicin; Tazobactam; Tetracyclines

2020
Current choices of antibiotic treatment for Pseudomonas aeruginosa infections.
    Current opinion in infectious diseases, 2020, Volume: 33, Issue:6

    Topics: Anti-Bacterial Agents; Antimicrobial Stewardship; beta-Lactamase Inhibitors; beta-Lactams; Cefiderocol; Cephalosporins; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Humans; Phage Therapy; Pseudomonas aeruginosa; Pseudomonas Infections

2020
A plethora of carbapenem resistance in
    Journal of chemotherapy (Florence, Italy), 2021, Volume: 33, Issue:3

    Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Bacteriophages; beta-Lactamases; beta-Lactams; Carbapenems; Cefiderocol; Cephalosporins; Colistin; Drug Resistance, Multiple, Bacterial; Humans; Membrane Transport Proteins; Microbial Sensitivity Tests; Polymyxin B; Tetracyclines

2021
Pharmacokinetics/Pharmacodynamics and tolerability of cefiderocol in the clinical setting.
    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2022, Volume: 35 Suppl 2

    Topics: Adult; Albumins; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Blood Proteins; Catechols; Cefiderocol; Cephalosporins; Cilastatin, Imipenem Drug Combination; Humans; Iron; Meropenem

2022

Other Studies

4 other study(ies) available for beta-lactams and cefiderocol

ArticleYear
TonB-Dependent Receptor Repertoire of Pseudomonas aeruginosa for Uptake of Siderophore-Drug Conjugates.
    Antimicrobial agents and chemotherapy, 2018, Volume: 62, Issue:6

    Topics: Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Bacterial Proteins; beta-Lactams; Biological Transport; Carrier Proteins; Cefiderocol; Cell Membrane Permeability; Cephalosporins; Membrane Proteins; Monobactams; Pseudomonas aeruginosa; Siderophores; Thiazoles

2018
The Role of Iron and Siderophores in Infection, and the Development of Siderophore Antibiotics.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2019, 11-13, Volume: 69, Issue:Suppl 7

    Topics: Bacterial Infections; beta-Lactams; Cefiderocol; Cephalosporins; Drug Design; Drug Development; Drug Resistance, Bacterial; Gram-Negative Bacteria; Humans; Iron; Models, Molecular; Siderophores

2019
NDM-35-Producing ST167
    Antimicrobial agents and chemotherapy, 2022, 08-16, Volume: 66, Issue:8

    Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cefiderocol; Cephalosporins; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; Microbial Sensitivity Tests

2022
Determination of potential combination of non-β-lactam, β-lactam, and β-lactamase inhibitors/β-lactam enhancer against class D oxacillinases producing Acinetobacter baumannii: Evidence from in-vitro, molecular docking and dynamics simulation.
    Journal of cellular biochemistry, 2023, Volume: 124, Issue:7

    Topics: Acinetobacter baumannii; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Cefepime; Cefiderocol; Lactams; Molecular Docking Simulation

2023